Corporate Integrity Agreements

10 Key Points for the Healthcare Industry

January 31, 2013

Complimentary Webinar

Archived media:

  • Webinar replay

McGuireWoods lawyers provided an in-depth analysis of the key business and legal considerations arising from corporate integrity agreements from the perspectives of healthcare, medical device and pharmaceutical companies who enter into them, and their various stakeholders.


  • Common elements of a corporate integrity agreement
  • Negotiating a corporate integrity agreement
  • Maintaining and navigating compliance
  • Analyzing impacts on the business
  • Analyzing impacts on valuation and marketability


  • Christina M. Egan, Partner, McGuireWoods LLP
  • Jeffrey E. Rogers, Partner, McGuireWoods LLP
  • Helen H. Suh, Associate, McGuireWoods LLP
  • Katherine C. Lin, Associate, McGuireWoods LLP